BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 32322977)

  • 21. Autologous hematopoietic stem cell transplantation for systemic sclerosis.
    Milanetti F; Bucha J; Testori A; Burt RK
    Curr Stem Cell Res Ther; 2011 Mar; 6(1):16-28. PubMed ID: 20955159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Autologous stem cell transplantation in systemic sclerosis].
    Henes JC; Wirths S; Kötter I
    Z Rheumatol; 2016 Oct; 75(8):762-769. PubMed ID: 27510996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autologous hematopoietic stem cell transplantation improves long-term survival-data from a national registry.
    Blank N; Schmalzing M; Moinzadeh P; Oberste M; Siegert E; Müller-Ladner U; Riemekasten G; Günther C; Kötter I; Zeidler G; Pfeiffer C; Juche A; Jandova I; Ehrchen J; Susok L; Schmeiser T; Sunderkötter C; Distler JHW; Worm M; Kreuter A; Keyßer G; Lorenz HM; Krieg T; Hunzelmann N; Henes J;
    Arthritis Res Ther; 2022 Nov; 24(1):258. PubMed ID: 36424638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients?
    Oliveira MC; Labopin M; Henes J; Moore J; Del Papa N; Cras A; Sakellari I; Schroers R; Scherer HU; Cuneo A; Kyrcz-Krzemien S; Daikeler T; Alexander T; Finke J; Badoglio M; Simões B; Snowden JA; Farge D
    Bone Marrow Transplant; 2016 Apr; 51(4):501-5. PubMed ID: 26642332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunological Adverse Events After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients.
    Strunz PP; Froehlich M; Gernert M; Schwaneck EC; Fleischer A; Pecher AC; Tony HP; Henes JC; Schmalzing M
    Front Immunol; 2021; 12():723349. PubMed ID: 34539659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autologous haematopoietic stem cell transplantation restores the suppressive capacity of regulatory B cells in systemic sclerosis patients.
    Lima-Júnior JR; Arruda LCM; Gonçalves MS; Dias JBE; Moraes DA; Covas DT; Simões BP; Oliveira MC; Malmegrim KCR
    Rheumatology (Oxford); 2021 Dec; 60(12):5538-5548. PubMed ID: 33724344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Autologous peripheral stem cell transplantation in systemic sclerosis: An important step forward, but we must temper our enthusiasm!].
    Mouthon L
    Rev Med Interne; 2024 Feb; 45(2):100-103. PubMed ID: 38238136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Case Report: Effectiveness of secukinumab in systemic sclerosis with early skin progress after autologous hematopoietic stem cell transplantation and end-stage kidney disease.
    Strunz PP; Labinsky H; Nagler LK; Portegys J; Froehlich M; Gernert M; Schmalzing M
    Front Immunol; 2023; 14():1294496. PubMed ID: 38045701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Automatic Quantitative Computed Tomography Evaluation of the Lungs in Patients With Systemic Sclerosis Treated With Autologous Stem Cell Transplantation.
    Wada DT; de Almeida FA; de Moraes DA; Dias JBE; Baddini-Martinez J; Oliveira MC; Koenigkam-Santos M
    J Clin Rheumatol; 2020 Oct; 26(7S Suppl 2):S158-S164. PubMed ID: 31868835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low B cell counts as risk factor for infectious complications in systemic sclerosis after autologous hematopoietic stem cell transplantation.
    Gernert M; Tony HP; Schwaneck EC; Fröhlich M; Schmalzing M
    Arthritis Res Ther; 2020 Aug; 22(1):183. PubMed ID: 32771029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety profile of autologous hematopoietic stem cell mobilization and transplantation in patients with systemic sclerosis.
    Helbig G; Widuchowska M; Koclęga A; Kopińska A; Kopeć-Mędrek M; Gaweł WB; Spałek A; Żak J; Grygoruk-Wiśniowska I; Liwoch R; Kucharz E; Markiewicz M
    Clin Rheumatol; 2018 Jun; 37(6):1709-1714. PubMed ID: 29256111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hematopoietic Stem Cell Transplantation Improves Functional Outcomes of Systemic Sclerosis Patients.
    Costa-Pereira KR; Guimarães AL; Moraes DA; Dias JBE; Garcia JT; de Oliveira-Cardoso EA; Zombrilli A; Leopoldo V; Costa TM; Simões BP; Oliveira MC
    J Clin Rheumatol; 2020 Oct; 26(7S Suppl 2):S131-S138. PubMed ID: 31397762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hematopoietic stem cell transplantation for systemic sclerosis: history and current status.
    Burt RK; Milanetti F
    Curr Opin Rheumatol; 2011 Nov; 23(6):519-29. PubMed ID: 21857226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis With Marked Improvement in Health-Related Quality of Life.
    Maltez N; Puyade M; Wang M; Lansiaux P; Marjanovic Z; Charles C; Steele R; Baron M; Colmegna I; Hudson M; Farge D;
    Arthritis Rheumatol; 2021 Feb; 73(2):305-314. PubMed ID: 32909693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis.
    Vonk MC; Marjanovic Z; van den Hoogen FH; Zohar S; Schattenberg AV; Fibbe WE; Larghero J; Gluckman E; Preijers FW; van Dijk AP; Bax JJ; Roblot P; van Riel PL; van Laar JM; Farge D
    Ann Rheum Dis; 2008 Jan; 67(1):98-104. PubMed ID: 17526554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pregnancy and childbirth after treatment with autologous hematopoietic stem cell transplantation for severe systemic sclerosis requiring parenteral nutrition. Ethical issues.
    Tyndall AJ; Joly F; Carbonne B; Deligny CN; Farge DC
    Clin Exp Rheumatol; 2008; 26(6):1122-4. PubMed ID: 19210885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The arguments favoring autologous haematopoietic stem cell transplantation in systemic scleroderma].
    Pugnet G
    Rev Med Interne; 2024 Feb; 45(2):104-108. PubMed ID: 38267322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Australian rheumatologists' perception of autologous haemopoietic stem cell transplantation for the treatment of systemic sclerosis: a cross-sectional survey.
    Penglase R; Girgis L; Englert H; Ma D; Moore J
    Intern Med J; 2024 May; ():. PubMed ID: 38821884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease.
    Binks M; Passweg JR; Furst D; McSweeney P; Sullivan K; Besenthal C; Finke J; Peter HH; van Laar J; Breedveld FC; Fibbe WE; Farge D; Gluckman E; Locatelli F; Martini A; van den Hoogen F; van de Putte L; Schattenberg AV; Arnold R; Bacon PA; Emery P; Espigado I; Hertenstein B; Hiepe F; Kashyap A; Kötter I; Marmont A; Martinez A; Pascual MJ; Gratwohl A; Prentice HG; Black C; Tyndall A
    Ann Rheum Dis; 2001 Jun; 60(6):577-84. PubMed ID: 11350846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Multiple sclerosis: interventions to halt disease : Which patients can be considered for autologous stem cell transplantation].
    Willison AG; Meuth SG
    Nervenarzt; 2022 Oct; 93(10):987-999. PubMed ID: 35951049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.